Skip to Content
Søk Menu

Mehdi Osooli

Reducing Opioid Use in Inflammatory Bowel Disease: A Critical Need

/ Mehdi Osooli
ECCO25IBD Play the Video 06:52
Peter Bossuyt

There Is a Lack of Data on the Effect of Dose Optimization

/ Peter Bossuyt
CrohnsECCO25 Play the Video 05:50
Per Hall

Making Primary Breast Cancer Prevention a Reality

/ Per Hall
Bröstcancer Play the Video 03:48
Michael Savona

AML: Oral Decitabine–Cedazuridine Is Equivalent to Intravenous Decitabine

/ Michael Savona
AMLLeukemi Play the Video 08:00

Prospects for the Use of Antibodies Against Parkinson’s Disease: A Multi-Edged Sword?

/ Daniel E. Otzen / Nikos Hatzakis / Céline Galvagnion / Martin Lauritzen / Krzysztof Kucharz
Parkinson

Fredrik Schjesvold: Bridging Science and Clinical Innovation                                                                                      

/ Jan Andreasen
Myelom

Advancing Myeloma Research and Treatment: An Interview with Fredrik Schjesvold

/ Fredrik Schjesvold / Jan Andreasen
Myelom

Liposomal Daunorubicin + Cytarabine: Enhanced Synergistic Antineoplastic Effect in AML Treatment

/ Andrea Lenartova / Jan Andreasen
AML

CAR-T Will Transform the Treatment of Malignant Diseases, But Challenges Remain in Selection, Logistics, and Toxicity

/ Julian Hamfjord / Jan Andreasen
CancerCAR-T

Highlights From the Nordic Urothelial Cancer Oncology Group (NUCOG)

/ Katrine Ørum / Helle Pappot / Anders Ullén
Blåscancer
Back to top